Please enable JavaScript to continue using this application.

Compare $OTLK vs $TNYA | Chartloom

Compare

$OTLK vs $TNYA

Outlook Therapeutics Inc · Tenaya Therapeutics Inc

OTLK

Outlook Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Compare $OTLK vs $TNYA

Comparing Outlook Therapeutics Inc and Tenaya Therapeutics Inc

OTLKOutlook Therapeutics Inc

TNYATenaya Therapeutics Inc

OTLKOutlook Therapeutics Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.58x

Rev growth (TTM)

-171.2%

YTD performance

-9.3%

52W performance

-52.5%

FCF yield

-50.1%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OTLK

TNYA

Detailed metrics comparison

OTLK

Outlook Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

OTLK$112M

TNYA$126M

Enterprise Value

OTLK$119M

TNYA$48M

Price

OTLK$0.60

TNYA$0.58

P/E Ratio

OTLKN/A

TNYAN/A

P/S Ratio

OTLK0.00x

TNYA94.33x

EV/Sales

OTLK1,109.27x

TNYA35.84x

EV/EBITDA

OTLK0.00x

TNYA0.00x

P/B Ratio

OTLK13.76x

TNYA1.82x

P/FCF Ratio

OTLKN/A

TNYAN/A

EV/FCF

OTLK-2.12x

TNYA-0.91x

PEG Ratio

OTLKN/A

TNYAN/A

Forward P/E (NTM)

OTLKN/A

TNYAN/A

Forward P/S (NTM)

OTLK3.58x

TNYA20.11x

Revenue (TTM)

OTLK$-1M

TNYA$1M

Revenue Growth (YoY)

OTLK-171.2%

TNYAN/A

Forward Rev Growth

OTLK26.4%

TNYA-49.9%

Gross Margin (TTM)

OTLK203.8%

TNYA0.0%

Operating Margin (TTM)

OTLK0.0%

TNYA0.0%

EBITDA Margin (TTM)

OTLK5181.7%

TNYA-5657.2%

Net Margin (TTM)

OTLK5703.4%

TNYA-7724.0%

FCF Margin (TTM)

OTLKN/A

TNYA-3939.2%

Net Income (TTM)

OTLK$-61M

TNYA$-103M

FCF (TTM)

OTLK$-56M

TNYA$-53M

EPS (TTM)

OTLK-$0.45

TNYA-$0.47

ROE (TTM)

OTLK-41551.0%

TNYA-10805.0%

ROA (TTM)

OTLK-28798.0%

TNYA-8584.0%

ROIC (TTM)

OTLK-16327.0%

TNYA-10805.0%

Cash

OTLK$11M

TNYA$78M

Debt

OTLK$18M

TNYA$0

Net Cash/Debt

OTLK$-7M

TNYA$78M

Current Ratio (TTM)

OTLK0.81x

TNYA4.52x

Quick Ratio (TTM)

OTLK0.45x

TNYA4.34x

Debt/Equity (TTM)

OTLK3.04x

TNYA0.00x

Debt/Assets (TTM)

OTLK0.0%

TNYA0.0%

Interest Coverage (TTM)

OTLKN/A

TNYAN/A

Net Debt/EBITDA (TTM)

OTLK0.00x

TNYA0.00x

Beta

OTLK0.64

TNYA2.87

52W Performance

OTLK-52.5%

TNYA-68.3%

YTD Performance

OTLK-9.3%

TNYA-21.0%

% from 52W High

OTLK-76.4%

TNYA-75.3%

% from 52W Low

OTLK271.8%

TNYA11.4%

Asset Turnover (TTM)

OTLK0.01x

TNYA0.00x

FCF Yield (TTM)

OTLK-50.1%

TNYA-41.8%

Earnings Yield (TTM)

OTLK-54.6%

TNYA-81.9%

Dividend Yield (TTM)

OTLKN/A

TNYAN/A

Rule of 40

OTLK5,010.5

TNYA-3,939.2

EV/GP/RG

OTLKN/A

TNYAN/A

Ticker research

View OTLK research View TNYA research

Metric	OTLK Outlook Therapeutics Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$112M	$126M
Enterprise Value	$119M	$48M
Price	$0.60	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	94.33x
EV/Sales	1,109.27x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.76x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.12x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.58x	20.11x
Revenue & Growth
Revenue (TTM)	$-1M	$1M
Revenue Growth (YoY)	-171.2%	N/A
Forward Rev Growth	26.4%	-49.9%
Profitability
Gross Margin (TTM)	203.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5181.7%	-5657.2%
Net Margin (TTM)	5703.4%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-61M	$-103M
FCF (TTM)	$-56M	$-53M
EPS (TTM)	-$0.45	-$0.47
ROE (TTM)	-41551.0%	-10805.0%
ROA (TTM)	-28798.0%	-8584.0%
ROIC (TTM)	-16327.0%	-10805.0%
Financial Health
Cash	$11M	$78M
Debt	$18M	$0
Net Cash/Debt	$-7M	$78M
Current Ratio (TTM)	0.81x	4.52x
Quick Ratio (TTM)	0.45x	4.34x
Debt/Equity (TTM)	3.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	2.87
52W Performance	-52.5%	-68.3%
YTD Performance	-9.3%	-21.0%
% from 52W High	-76.4%	-75.3%
% from 52W Low	271.8%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-50.1%	-41.8%
Earnings Yield (TTM)	-54.6%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,010.5	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View OTLK research	View TNYA research

Valuation

P/S Ratio

OTLK

0.00x

TNYA

94.33x

EV/FCF

OTLK

-2.12x

TNYA

-0.91x

Growth & revenue

Revenue Growth TTM

OTLK

-171.2%

Forward Revenue Growth

OTLK

26.4%

TNYA

-49.9%

Profitability & performance

Gross Margin

OTLK

203.8%

TNYA

0.0%

ROE

TNYA

-10805.0%

OTLK

-41551.0%

FCF Yield %

TNYA

-41.8%

OTLK

-50.1%

52-Week Performance

OTLK

-52.5%

TNYA

-68.3%

Detailed metrics comparison

OTLK

Outlook Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

OTLK$112M

TNYA$126M

Enterprise Value

OTLK$119M

TNYA$48M

Price

OTLK$0.60

TNYA$0.58

P/E Ratio

OTLKN/A

TNYAN/A

P/S Ratio

OTLK0.00x

TNYA94.33x

EV/Sales

OTLK1,109.27x

TNYA35.84x

EV/EBITDA

OTLK0.00x

TNYA0.00x

P/B Ratio

OTLK13.76x

TNYA1.82x

P/FCF Ratio

OTLKN/A

TNYAN/A

EV/FCF

OTLK-2.12x

TNYA-0.91x

PEG Ratio

OTLKN/A

TNYAN/A

Forward P/E (NTM)

OTLKN/A

TNYAN/A

Forward P/S (NTM)

OTLK3.58x

TNYA20.11x

Revenue (TTM)

OTLK$-1M

TNYA$1M

Revenue Growth (YoY)

OTLK-171.2%

TNYAN/A

Forward Rev Growth

OTLK26.4%

TNYA-49.9%

Gross Margin (TTM)

OTLK203.8%

TNYA0.0%

Operating Margin (TTM)

OTLK0.0%

TNYA0.0%

EBITDA Margin (TTM)

OTLK5181.7%

TNYA-5657.2%

Net Margin (TTM)

OTLK5703.4%

TNYA-7724.0%

FCF Margin (TTM)

OTLKN/A

TNYA-3939.2%

Net Income (TTM)

OTLK$-61M

TNYA$-103M

FCF (TTM)

OTLK$-56M

TNYA$-53M

EPS (TTM)

OTLK-$0.45

TNYA-$0.47

ROE (TTM)

OTLK-41551.0%

TNYA-10805.0%

ROA (TTM)

OTLK-28798.0%

TNYA-8584.0%

ROIC (TTM)

OTLK-16327.0%

TNYA-10805.0%

Cash

OTLK$11M

TNYA$78M

Debt

OTLK$18M

TNYA$0

Net Cash/Debt

OTLK$-7M

TNYA$78M

Current Ratio (TTM)

OTLK0.81x

TNYA4.52x

Quick Ratio (TTM)

OTLK0.45x

TNYA4.34x

Debt/Equity (TTM)

OTLK3.04x

TNYA0.00x

Debt/Assets (TTM)

OTLK0.0%

TNYA0.0%

Interest Coverage (TTM)

OTLKN/A

TNYAN/A

Net Debt/EBITDA (TTM)

OTLK0.00x

TNYA0.00x

Beta

OTLK0.64

TNYA2.87

52W Performance

OTLK-52.5%

TNYA-68.3%

YTD Performance

OTLK-9.3%

TNYA-21.0%

% from 52W High

OTLK-76.4%

TNYA-75.3%

% from 52W Low

OTLK271.8%

TNYA11.4%

Asset Turnover (TTM)

OTLK0.01x

TNYA0.00x

FCF Yield (TTM)

OTLK-50.1%

TNYA-41.8%

Earnings Yield (TTM)

OTLK-54.6%

TNYA-81.9%

Dividend Yield (TTM)

OTLKN/A

TNYAN/A

Rule of 40

OTLK5,010.5

TNYA-3,939.2

EV/GP/RG

OTLKN/A

TNYAN/A

Ticker research

View OTLK research View TNYA research

Metric	OTLK Outlook Therapeutics Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$112M	$126M
Enterprise Value	$119M	$48M
Price	$0.60	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	94.33x
EV/Sales	1,109.27x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.76x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.12x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.58x	20.11x
Revenue & Growth
Revenue (TTM)	$-1M	$1M
Revenue Growth (YoY)	-171.2%	N/A
Forward Rev Growth	26.4%	-49.9%
Profitability
Gross Margin (TTM)	203.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5181.7%	-5657.2%
Net Margin (TTM)	5703.4%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-61M	$-103M
FCF (TTM)	$-56M	$-53M
EPS (TTM)	-$0.45	-$0.47
ROE (TTM)	-41551.0%	-10805.0%
ROA (TTM)	-28798.0%	-8584.0%
ROIC (TTM)	-16327.0%	-10805.0%
Financial Health
Cash	$11M	$78M
Debt	$18M	$0
Net Cash/Debt	$-7M	$78M
Current Ratio (TTM)	0.81x	4.52x
Quick Ratio (TTM)	0.45x	4.34x
Debt/Equity (TTM)	3.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	2.87
52W Performance	-52.5%	-68.3%
YTD Performance	-9.3%	-21.0%
% from 52W High	-76.4%	-75.3%
% from 52W Low	271.8%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-50.1%	-41.8%
Earnings Yield (TTM)	-54.6%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,010.5	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View OTLK research	View TNYA research